eTheRNA Competitors and Similar CompaniesClear all
eTheRNA's competitors and similar companies include PharmaCCX and MaveriX Oncology.
 eTheRNA eTheRNA immunotherapies is a biotech company developing immuno-oncology therapies based on its APC-activating messenger RNA platform. |  PharmaCCX PharmaCCX (also know as Contingent Commitment Exchange) is a company developing a pricing platform for the oncology drug market. |  MaveriX Oncology MaveriX Oncology is a biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies. | |
Founding Date | Founding Date 2013 | Founding Date 2017 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Antwerp, BE HQ Ghent, BE Hong Kong, HK Boston, US | Locations Boston, US HQ Stockholm, SE Zug, CH San Mateo, US | Locations Palo Alto, US HQ |
Employees | Employees 1104% decrease | Employees 558% increase | Employees 3 |
Funding | |||
Latest funding round | Latest funding round $ 38.3m (almost 6 years ago) | Latest funding round $ 3m (over 7 years ago) | Latest funding round $ 6.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 66.3m | Total funding raised $ 3m | Total funding raised $ 6.5m |
For sources of this data, please see the company profile
View Company Profiles
PharmaCCX
HQ
Boston, US
Employees
55↑ 8% increase
PharmaCCX (also know as Contingent Commitment Exchange) is a company developing a pricing platform for the oncology drug market.
View companyMaveriX Oncology
HQ
Palo Alto, US
Employees
3
MaveriX Oncology is a biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies.
View company